Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G Gerber

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Chirality|June 15, 2011
Stereoselective determination of the epimer mixtures of itraconazole in human blood plasma using HPLC and fluorescence detectionChristina Pyrgaki, Steve J Bannister, Lajos Gera, et al.
AIDS (London, England)|June 17, 2005
Indinavir protein-free concentrations when used in indinavir/ritonavir combination therapyJennifer R King, John G Gerber, Courtney V Fletcher, et al.
Chirality|March 18, 2005
Determination of the absolute configuration and solution conformation of the antifungal agents ketoconazole, itraconazole, and miconazole with vibrational circular dichroismDavid Dunmire, Teresa B Freedman, Laurence A Nafie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 8, 2008
Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteersJennifer J Kiser, John G Gerber, Julie A Predhomme, et al.
AIDS Research and Human Retroviruses|October 31, 2003
Protein binding in antiretroviral therapiesMarta Boffito, David J Back, Terrence F Blaschke, et al.
AIDS (London, England)|March 4, 2006
Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108Judith A Aberg, Susan L Rosenkranz, Carl J Fichtenbaum, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistanceHulin Wu, Yangxin Huang, Edward P Acosta, et al.
Antiviral Therapy|September 13, 2006
Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118)Barbara M Gripshover, Heather Ribaudo, Jorge Santana, et al.
AIDS (London, England)|March 2, 2002
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047Carl J Fichtenbaum, John G Gerber, Susan L Rosenkranz, et al.
Clinical Pharmacology and Therapeutics|August 9, 2005
Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockersMarshall J Glesby, Judith A Aberg, Michelle A Kendall, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Chirality|June 15, 2011
Stereoselective determination of the epimer mixtures of itraconazole in human blood plasma using HPLC and fluorescence detectionChristina Pyrgaki, Steve J Bannister, Lajos Gera, et al.
AIDS (London, England)|June 17, 2005
Indinavir protein-free concentrations when used in indinavir/ritonavir combination therapyJennifer R King, John G Gerber, Courtney V Fletcher, et al.
Chirality|March 18, 2005
Determination of the absolute configuration and solution conformation of the antifungal agents ketoconazole, itraconazole, and miconazole with vibrational circular dichroismDavid Dunmire, Teresa B Freedman, Laurence A Nafie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 8, 2008
Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteersJennifer J Kiser, John G Gerber, Julie A Predhomme, et al.
AIDS Research and Human Retroviruses|October 31, 2003
Protein binding in antiretroviral therapiesMarta Boffito, David J Back, Terrence F Blaschke, et al.
AIDS (London, England)|March 4, 2006
Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108Judith A Aberg, Susan L Rosenkranz, Carl J Fichtenbaum, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistanceHulin Wu, Yangxin Huang, Edward P Acosta, et al.
Antiviral Therapy|September 13, 2006
Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118)Barbara M Gripshover, Heather Ribaudo, Jorge Santana, et al.
AIDS (London, England)|March 2, 2002
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047Carl J Fichtenbaum, John G Gerber, Susan L Rosenkranz, et al.
Clinical Pharmacology and Therapeutics|August 9, 2005
Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockersMarshall J Glesby, Judith A Aberg, Michelle A Kendall, et al.
Pageof 3